SCHEMBL19969146

SCHEMBL19969146

CN(C(=O)C(Cc1cc(F)cc(F)c1)NC(=O)CN1c2ccccc2N(CC(=O)N[C@@H](Cc2cc(F)cc(F)c2)C(=O)N(C)c2ccc3c(c2)ncn3C)S1(=O)=O)c1ccc2c(c1)ncn2C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.35
MAPT P10636 2/20 0.35
KMT2A Q03164 2/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
GFER P55789 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
PYGL P06737 1/20 0.35
NPC1 O15118 4/20 0.34
RAB9A P51151 4/20 0.34
NOTUM Q6P988 2/20 0.34
TP53 P04637 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PSEN1 P49768 3/20 0.32
PSEN2 P49810 3/20 0.32
APH1B Q8WW43 3/20 0.32
NCSTN Q92542 3/20 0.32
APH1A Q96BI3 3/20 0.32
PSENEN Q9NZ42 3/20 0.32
MMP9 P14780 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19962023 1.00 ALDH1A1 (0.35) ALDH1A1MAPTKMT2ALMNAHTT
SCHEMBL19962022 0.84 PYGL (0.37) PYGLPSEN1PSEN2APH1BNCSTN
SCHEMBL19969320 0.84 PYGL (0.37) PYGLPSEN1PSEN2APH1BNCSTN
SCHEMBL18180288 0.84 PYGL (0.35) PYGLPSEN1PSEN2APH1BNCSTN
SCHEMBL19969008 0.84 PYGL (0.35) PYGLPSEN1PSEN2APH1BNCSTN
SCHEMBL19962139 0.83 MAPT (0.36) ALDH1A1MAPTKMT2ALMNAHTT
SCHEMBL19969215 0.83 MAPT (0.36) ALDH1A1MAPTKMT2ALMNAHTT
SCHEMBL19962095 0.82 PYGL (0.37) PYGLPSEN1PSEN2APH1BNCSTN
SCHEMBL19969222 0.82 PYGL (0.37) PYGLPSEN1PSEN2APH1BNCSTN
SCHEMBL19962078 0.82 OXTR (0.41) KMT2ALMNAPYGLNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180072997-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BRISTOL-MYERS SQUIBB COMPANY 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180072997-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION EIF2AK2, POLR2H, POLR2E ALDH1A1 2545/4885MAPT 1843/4885KMT2A 3986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.